| Advances in the assessment and control of the effector functions of therapeutic antibodies XR Jiang, A Song, S Bergelson, T Arroll, B Parekh, K May, S Chung, ... Nature reviews Drug discovery 10 (2), 101-111, 2011 | 363 | 2011 |
| Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics G Dennis, CTJ Holweg, SK Kummerfeld, DF Choy, AF Setiadi, ... Arthritis research & therapy 16, 1-18, 2014 | 359 | 2014 |
| Phosphorylation of nuclear MyoD is required for its rapid degradation AN Song, QI Wang, MG Goebl, MA Harrington Molecular and cellular biology 18 (9), 4994-4999, 1998 | 204 | 1998 |
| Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. MA Harrington, B Konicek, A Song, XL Xia, WJ Fredericks, ... Journal of Biological Chemistry 268 (28), 21271-21275, 1993 | 188 | 1993 |
| RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes A Song, YF Chen, K Thamatrakoln, TA Storm, AM Krensky Immunity 10 (1), 93-103, 1999 | 144 | 1999 |
| Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics S Gupta, V Devanarayan, D Finco, GR Gunn III, S Kirshner, S Richards, ... Journal of pharmaceutical and biomedical analysis 55 (5), 878-888, 2011 | 137 | 2011 |
| Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activities S Chung, V Quarmby, X Gao, Y Ying, L Lin, C Reed, C Fong, W Lau, ... MAbs 4 (3), 326-340, 2012 | 134 | 2012 |
| Transcriptional regulation of RANTES expression in T lymphocytes. A Song, T Nikolcheva, AM Krensky Immunological reviews 177, 236-245, 2000 | 127 | 2000 |
| Specific immune response to phospholipase B-like 2 protein, a host cell impurity in lebrikizumab clinical material SK Fischer, M Cheu, K Peng, J Lowe, J Araujo, E Murray, D McClintock, ... The AAPS journal 19, 254-263, 2017 | 90 | 2017 |
| A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes T Nikolcheva, S Pyronnet, S Chou, N Sonenberg, A Song, C Clayberger, ... The Journal of clinical investigation 110 (1), 119-126, 2002 | 85 | 2002 |
| Functional domains and DNA-binding sequences of RFLAT-1/KLF13, a Krüppel-like transcription factor of activated T lymphocytes A Song, A Patel, K Thamatrakoln, C Liu, D Feng, C Clayberger, ... Journal of Biological Chemistry 277 (33), 30055-30065, 2002 | 78 | 2002 |
| 2013 White Paper on recent issues in bioanalysis: ‘hybrid’ – the best of LBA and LCMS L Stevenson, F Garofolo, B DeSilva, I Dumont, S Martinez, M Rocci, ... Bioanalysis 5 (23), 2903-2918, 2013 | 74 | 2013 |
| Kruppel-like transcription factor 13 regulates T lymphocyte survival in vivo M Zhou, L McPherson, D Feng, A Song, C Dong, SC Lyu, L Zhou, X Shi, ... The Journal of Immunology 178 (9), 5496-5504, 2007 | 73 | 2007 |
| A multiplexed hybrid LC–MS/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical study K Xu, L Liu, M Maia, J Li, J Lowe, A Song, S Kaur Bioanalysis 6 (13), 1781-1794, 2014 | 69 | 2014 |
| 2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3–LBA, biomarkers and immunogenicity) L Amaravadi, A Song, H Myler, T Thway, S Kirshner, V Devanarayan, ... Bioanalysis 7 (24), 3107-3124, 2015 | 66 | 2015 |
| Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies—impact of effector cells S Chung, YL Lin, C Reed, C Ng, ZJ Cheng, F Malavasi, J Yang, ... Journal of Immunological Methods 407, 63-75, 2014 | 63 | 2014 |
| 2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3–LBA: immunogenicity, biomarkers and PK … S Gupta, S Richards, L Amaravadi, S Piccoli, B Desilva, R Pillutla, ... Bioanalysis 9 (24), 1967-1996, 2017 | 52 | 2017 |
| Pretreatment of a biological sample from an autoimmune disease subject K McCutcheon, A Song US Patent 7,601,335, 2009 | 51 | 2009 |
| Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake Y Shang, Y Mao, J Batson, SJ Scales, G Phillips, MR Lackner, K Totpal, ... Molecular cancer therapeutics 7 (9), 2599-2608, 2008 | 48 | 2008 |
| An in vitro FcRn- dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans S Chung, V Nguyen, YL Lin, J Lafrance-Vanasse, SJ Scales, K Lin, ... MAbs 11 (5), 942-955, 2019 | 46 | 2019 |
